Symposium Presentation 2.3
Satisfying Effectiveness Requirements for Novel ADHD Pharmacotherapies: Functional Impairment and Health-Related Quality of Life Outcome Measures in International Trials

Tuesday, October 22, 2013 1:00 PM
Paul Hodgkins, MSC, PhD, Health Economics, Shire Pharmaceuticals, Inc., Wayne, PA
See more of: Modern Approaches to Managing ADHD: A European Perspective
See more of: Symposium
Copyright ©2013 - American Academy of Child Adolescent Psychiatry. All Rights Reserved.